Enoxaparin Completed Phase 4 Trials for Enoxaparin (DB01225)

IndicationStatusPhase
DBCOND0077846 (Enoxaparin)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03528967Enoxaparin in the Prevention of Placental Insufficiency in Pregnant WomenPrevention